Treatment of 2',3'-anhydro pyrimidine nucleoside derivatives (1) with trime
thylaluminum afforded 1-(3-deoxy-3-methyl-beta-D-arabinofuranosyl)pyrimidin
e derivatives (2) and 1-(2-deoxy-2-methyl-beta-D-xylofuranosyl)pyrimidine d
erivatives (3) as a mixture in approximately 2 : 1 - 3 : 1 ratio via ring-o
pening of the epoxide involving the nucleophilic attack of trimethylaluminu
m at the 3' or 2'-position of 1.